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Abstract
We report a 41-year-old Chinese woman with intravascular large B-cell lymphoma diagnosed by percutaneous
renal biopsy. The patient was admitted to Nanfang Hospital of Southern Medical University, Guangzhou, China with
complaints of high spiking fever for a month and bilateral lower limb fatigue with difficulty ambulating for the
past 5 months.
She had renal dysfunction with a total urinary protein of 5.61 g/dL (56.1 g/L), serum albumin of 2.89 g/dL (28.9 g/
L), urea nitrogen of 2.24 mg/dL (1.6 mmol/L), and serum creatinine of 0.54 mg/dL (48 μmol/L). Bone marrow
biopsy revealed myeloproliferative disorder without abnormal myeloid or lymphocytic proliferation. Positron
Emission Tomography-Computed Tomography (PET-CT) showed marked bilateral swelling and enlargement of the
renal parenchyma with splenic enlargement and involvement of multiple vertebrae. Percutaneous renal biopsy
showed island-like accumulations of medium to large lymphoid cells in many areas of the interstitium, with round
vesicular nuclei containing distinct basophilic nucleoli. Immunohistochemical analysis together with other
supportive investigation confirmed the diagnosis of intravascular large B-cell lymphoma. Ten days later, she was
started on chemotherapy with CHOP (cyclophosphamide, doxorubicin, leurocristime and prednisone) for a week.
Palliative radiotherapy DT 40Gy/20F with other supportive treatment was provided for metastatic foci in the
medullary cavity of the sternum, T1-T7. The patient regained muscle strength in both lower limbs and was able to
walk again after three weeks. The patient was discharged after hepatic and renal function and proteinuria values
had returned to normal. Follow-up data shows the patient to be alive nine months after discharge.
Virtual Slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/4694676865681066.
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Background
Intravascular large B-cell lymphoma (IVLBCL) is a rare
variant of large B-cell lymphoma characterized by prolif-
eration of malignant lymphoid cells in small vessels of
organs such as skin, kidneys, adrenals, lungs, liver and
the central nervous system. Neurologic findings and
skin manifestations may present a clue clinically, while
fever of unknown origin without weight loss is a com-
mon non-specific symptom. Since Jothy et al first
reported a case of IVLBCL in kidney in 1981 [1], seven-
teen additional cases have been published in the
literature [2,3]. Most of these cases had malignant lym-
phoid cells localized within the glomerular capillaries.
One case reported the localization of lymphoma cells
within peritubular capillaries [4].
We report here a case with markedly enlarged kidney
showing clustering of lymphoma cells within the peri-
tubular capillaries.
Case presentation
A 41-year-old Chinese woman was referred to the
Department of Neurology, Nanfang Hospital of South-
ern Medical University, Guangzhou, China, with the
chief complaint of high spiking fever for approximately
a month with bilateral lower limb fatigue and difficulty
in defecation for more than five months. She had been
residing in Yingde City of Guangdong Province for 10
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years with no known prior exposure to any infectious or
occupational diseases. In July 2010, she was diagnosed
with ‘whole body multiple metastases of lymphoma’.
Due to economic reasons, the patient was transferred at
the end of July 2010 to Donghua Hospital of Yingde
City for treatment of her symptoms of infection, consti-
pation, low potassium and leukopenia. By August 2010,
the patient was unable to walk with bilateral lower limb
fatigue and was subsequently admitted to the Depart-
ment of Radiation Oncology at Nanfang Hospital.
On admission, the patient was 152 cm tall and
weighed 52 kg. Her blood pressure was 112/82 mm Hg,
temperature 38.5°C with a respiratory rate of 16 times
per minute. No superficial enlarged lymph nodes were
palpable. Inspiratory and expiratory sounds were normal
to auscultation. There was no percussion tenderness
over the liver or kidney. Muscle strength of upper limbs
was normal and that of lower limbs was 3/5. Bilateral
Babinski sign was positive. Sensation of pain and touch
below the knees were slightly reduced. Physiological
reflexes were slightly active. There was no pedal edema.
All other physical tests were normal.
Laboratory findings were as follows: total urinary pro-
tein, 5.61 g/dL (56.1 g/L); serum albumin, 2.89 g/dL
(28.9 g/L); blood urea nitrogen, 2.24 mg/dL (1.6 mmol/
L); and creatinine, 0.54 mg/dL (48 μmol/L). The urine
protein and occult blood values were negative. Urinary
leukocyte count was 48/μL (4.8 × 107/L); erythrocyte
count, 3.78 × 106/μL (3.78T/L); hemoglobin, 9.9 g/dL
(99 g/L); lymphocyte count, 1.12 × 103/μL (1.12 g/l) and
platelet count, 1.73 × 105/μL (173 g/l).
Bone marrow aspiration was performed and the slide
smear revealed 41.5% immature cells of unknown ori-
gin. Positron Emission Tomography-Computed Tomo-
graphy (PET-CT) showed the following changes
(Figure 1). The bilateral renal parenchyma was mark-
edly swollen with obvious diffuse increase in signal
intensity. Increased signal intensity was observed in
multiple thoracic vertebral bodies, multiple lumbar
vertebral bodies, bilateral sacrum, ilium, proximal
humerus and femur medullary cavities. Mildly
increased signal intensity was observed in both lungs.
The possibility of interstitial pneumonia was not
excluded. Multiple bilateral neck and mediastinum
lymph nodes were mildly enlarged with inflammatory
proliferation. The spleen was markedly enlarged with
mild diffuse increase in signal intensity. A large
volume of pelvic effusion was detected.
The day after admission, a percutaneous renal biopsy
was performed. Eleven glomeruli were present with no
evidence of mesangial cell proliferation or capillary wall
thickening. Island-like accumulations of medium to
large lymphoid cells were observed in many areas of the
interstitium, with round vesicular nuclei containing
distinct basophilic nucleoli (Figure 2A). Immunohisto-
chemical analysis showed the atypical lymphoid cells to
be positive for B-cell markers CD20 (Figure 2B) and
negative for CK, CD3, CD45RO and CD10. They were
positive for large B-cell lymphoma marker mum-1 (Fig-
ure 2C). Immunohistochemical staining using anti-
CD34 confirmed the accumulation of lymphoid cells to
be localized within the peritubular capillary lumina (Fig-
ure 2D). Immunofluorescence revealed negative staining
of IgG, IgA, IgM, C3 and C1q with no glomerular
immune deposits. Electron microscopy did not detect
any electron dense deposits, but did show a cluster of
atypical lymphocytes encircled by a peritubular capillary
wall.
Pathologic examinations of percutaneous renal biop-
sies confirmed the diagnosis of intravascular large B-cell
lymphoma of Stage IVE. The patient returned to the
local hospital for symptomatic treatment after diagnosis.
Ten days later she was readmitted into Nanfang hospital
due to sudden bilateral lower limb fatigue and inability
to walk. She was treated with chemotherapy consisting
of CHOP (cyclophosphamide 1.0 g D1+Doxorubicin 60
mg D1+leurocristime 2 mg D1+Prednisone 100 mg D1-
5) for a week. Palliative radiotherapy DT 40Gy/20F and
other supportive treatment were provided for metastatic
foci in the medullary cavity of sternum, T1-7. The
patient regained muscle strength in both lower limbs
and was able to walk again. She was discharged after
hepatic and renal function values had returned to nor-
mal. Follow-up data shows the patient to be alive, nine
months after discharge.
Conclusions
Intravascular Large B-cell Lymphoma (IVLBCL), also
described as intravascular lymphomatosis, angiotropic
large cell lymphoma, and malignant angioendothelioma-
tosis, is a very rare subtype of Non-Hodgkin’s lym-
phoma. The true incidence is unknown and there is no
known sex predilection. The prognosis is usually very
poor despite use of chemotherapy. Most patients present
with fever of unknown origin and nonspecific cutaneous
and neurologic manifestations. The renal involvement
with IVLBCL has been classified as either intraglomeru-
lar growth or tubulointerstitial invasion. Microscopically,
it is characterized by the proliferation and infiltration of
lymphoma cells in capillaries and venules. No obvious
extravascular tumor mass or detectable circulating
tumor cells are observed in the peripheral blood.
The clinical manifestations include symptoms related
to multi-organ failure [5]. In the past, the diagnosis was
usually made at autopsy. With increased awareness and
improved physical health check-ups more cases have
been detected during life allowing for active and effec-
tive treatment.
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The first case with IVLBCL was diagnosed by renal
biopsy in 1981 [1]. Since then, several other studies have
reported similar cases [6-8]. The common pathologic
finding is localization of the lymphoma cells within the
lumina of the glomerular capillaries. Bilateral marked
nephromegaly is the other major clinical feature in
patients with the tubulointerstitial type of disease. Renal
size has been reported to improve rapidly in response to
chemotherapy. Clinical findings associated with IVLBCL
are reported to be acute renal failure (ARF) and nephri-
tic-range proteinuria. The ARF might be caused by the
obstruction of glomerular circulation due to the invasion
of the lymphoid cells, as has been suggested in acute
proliferative glomerulonephritis, resulting in a loss of
renal function. The greater the proportion of glomeruli
that is affected by the infiltration of tumor cells, the
more the renal function has deteriorated, consistent
with the view that the presence of tumor cells impair
glomerular function. In the IVLBCL cases with nephro-
tic range proteinuria, histology of renal biopsies revealed
minimal glomerular lesions because of the absence of
immune deposits in the glomeruli.
In the present case, lymphoma cells involved multiple
loci including the kidney, skeletal system, lungs, lymph
nodes, spleen, and pelvic cavity. The mechanism of
renal dysfunction could be due to the obstruction of
peritubular capillaries with increased post glomerular
vascular resistance, compression of tubules, or modula-
tion of the tubuloglomerular feedback mechanism. The
impairment of the patient’s skeletal and pulmonary sys-
tems resulted in movement dysfunction and interstitial
pneumonia. Lymph node inflammatory proliferation is
Figure 1 PET-CT shows foci with high signal intensity in bilateral kidneys, multiple vertebra, bilateral sacrum and ilium.
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considered with multiple bilateral neck and mediasti-
num lymph nodes enlargement. This indicates the
occlusion of lymphoma cells in the vasculature, causing
thrombosis and multiple system dysfunctions [9]. The
enlarged lymph nodes may block drainage of fluid that
lubricates the pelvic cavity, causing effusion accumula-
tions and symptoms such as lower limb edema, pelvic
effusion, and anorexia.
In the present case, the tumor cell accumulation is
demonstrated to be confined within the peritubular
capillary walls, by anti-CD34 staining. These lymphoid
cells are positive for B-cell markers CD20, CD79a, and
PAX-5. They are also positive for mum-1 and bcl-6,
suggesting origin from the active B lymphocyte. The
immunohistochemical analysis confirmed the diagnosis
of IVLBCL. Although the cause for highly selective peri-
tubular capillary localization of the lymphoma cell is
unclear, it is possible the large size of the lymphoma
cell results in entrapment of tumor cells within the glo-
merular rather than peritubular capillaries. The exami-
nation of the bone marrow was not helpful in the
diagnosis of this case unlike other cases reported in lit-
erature [10].
In conclusion, when tubulointerstitial cell infiltration
is found in a patient with bilateral marked nephrome-
galy and renal dysfunction without proteinuria, intra-
Figure 2 Hematoxylin & Eosin (H&E) shows mild changes in glomeruli. Island-like infiltrations of medium to large atypical lymphoid cells
with hyperchromatic nuclei are seen in many areas of the interstitium (A). (Magnification, ×200) Immunohistochemical staining shows the
lymphoid cells to be positive for B-cell markers CD20 (B) and large B-cell lymphoma markers mum-1 (C). (Magnification, ×100)
Immunohistochemical staining using anti-CD34 shows the accumulation of lymphoid cells to be localized within the peritubular capillary lumina
(D). (Magnification, ×400).
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peritubular capillary lymphoma should be considered as
a possible diagnosis.
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